You searched for
We found 9 articles
A Study of BMS-582949 in Patients With Moderate to Severe Plaque Psoriasis
The purpose of this clinical research study is to learn if BMS-582949 alone is an effective treatment for moderate to…
01 Jan 2013
Metvix PDT in Patients With “High Risk” Basal Cell Carcinoma
The variable “complete response” after one or two Metvix treatment cycles will be used as the basis for the justification…
01 Jan 2013
Study to Compare the Efficacy and Safety of CC-5013 Vs. Placebo in Subjects With Metastatic Malignant Melanoma.
Subjects are randomized to one of two treatment arms. All subjects are screened for eligibility within 28 days prior to…
01 Jan 2013
A Study of LY573636 in Treating Patients With Malignant Melanoma
The primary objective of this study is to determine the objective response rate (complete and partial response) for patients who…
01 Jan 2013
Vaccine Therapy for Patients With Stage III Melanoma
This is a Phase 3 study in patients with melanoma that has spread to the lymph nodes (stage III), and…
01 Jan 2013
Isavuconazole in the Treatment of Candidemia and Other Invasive Candida Infections
The purpose of the study is to compare the safety and efficacy of Isavuconazole versus caspofungin followed by voriconazole in…
01 Jan 2013
Safety Study of Oral BTA9881 to Treat Respiratory Syncytial Virus Infections
This is a placebo-controlled, double-blind, randomised, single dose escalation Phase I clinical trial to determine the safety and tolerability of…
01 Jan 2013
Study of Pemetrexed and Carboplatin Compared With Etoposide Carboplatin to Treat Extensive-Stage Small Cell Lung Cancer
This study is a Phase 3, global, multi-center, open-label study of patients with extensive-stage small cell lung cancer. Eligible patients…
01 Jan 2013
BUILD 3: Bosentan Use in Interstitial Lung Disease
BUILD 3 is a prospective, multicenter, randomized, double-blind, parallel group, placebo-controlled, event-driven, group sequential, phase III superiority study. The primary…
01 Jan 2013
